Sight Sciences, Inc.
SGHT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $182 | $251 | $584 | $835 |
| - Cash | $120 | $138 | $185 | $261 |
| + Debt | $40 | $35 | $35 | $34 |
| Enterprise Value | $102 | $148 | $434 | $608 |
| Revenue | $80 | $81 | $71 | $49 |
| % Growth | -1.5% | 13.6% | 45.7% | – |
| Gross Profit | $68 | $69 | $59 | $40 |
| % Margin | 85.5% | 85.3% | 82.7% | 82.4% |
| EBITDA | -$46 | -$49 | -$80 | -$57 |
| % Margin | -57.5% | -61% | -112.8% | -116.8% |
| Net Income | -$52 | -$56 | -$86 | -$63 |
| % Margin | -64.5% | -68.5% | -120.9% | -128.6% |
| EPS Diluted | -1.03 | -1.14 | -1.8 | -1.33 |
| % Growth | 9.6% | 36.7% | -35.3% | – |
| Operating Cash Flow | -$22 | -$47 | -$76 | -$53 |
| Capital Expenditures | -$0 | -$1 | -$1 | -$1 |
| Free Cash Flow | -$23 | -$48 | -$77 | -$53 |